Bolt Biotherapeutics (BOLT) Misses Q3 EPS by 372c

Bolt Biotherapeutics (NASDAQ: BOLT) reported Q3 EPS of ($3.72). Revenue for the quarter came in at $2.17 million.

For earnings history and earnings-related data on Bolt Biotherapeutics (BOLT) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue